Joseph Dottino

494 total citations
22 papers, 346 citations indexed

About

Joseph Dottino is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Joseph Dottino has authored 22 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Reproductive Medicine, 7 papers in Obstetrics and Gynecology and 6 papers in Oncology. Recurrent topics in Joseph Dottino's work include Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Economic and Financial Impacts of Cancer (4 papers). Joseph Dottino is often cited by papers focused on Ovarian cancer diagnosis and treatment (12 papers), Endometrial and Cervical Cancer Treatments (7 papers) and Economic and Financial Impacts of Cancer (4 papers). Joseph Dottino collaborates with scholars based in United States and United Kingdom. Joseph Dottino's co-authors include Laura J. Havrilesky, Angeles Alvarez Secord, Jae Huh, Yukio Sonoda, Douglas A. Levine, Nadeem R. Abu‐Rustum, Oliver Zivanovic, Richard R. Barakat, Kimberly Levinson and S. Dennis and has published in prestigious journals such as Journal of Controlled Release, American Journal of Obstetrics and Gynecology and Obstetrics and Gynecology.

In The Last Decade

Joseph Dottino

19 papers receiving 341 citations

Peers

Joseph Dottino
Marianne J. Rutten Netherlands
Janos Balega United Kingdom
Nagindra Das United Kingdom
Oded Raban Israel
Olivia Foley United States
Jason Yap United Kingdom
Shayan Dioun United States
Danny Barnhill United States
Marianne J. Rutten Netherlands
Joseph Dottino
Citations per year, relative to Joseph Dottino Joseph Dottino (= 1×) peers Marianne J. Rutten

Countries citing papers authored by Joseph Dottino

Since Specialization
Citations

This map shows the geographic impact of Joseph Dottino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Dottino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Dottino more than expected).

Fields of papers citing papers by Joseph Dottino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Dottino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Dottino. The network helps show where Joseph Dottino may publish in the future.

Co-authorship network of co-authors of Joseph Dottino

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Dottino. A scholar is included among the top collaborators of Joseph Dottino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Dottino. Joseph Dottino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abel, Mary Kathryn, Amy Bregar, Allison Gockley, et al.. (2025). Neoadjuvant Chemotherapy, Case Volume, and Mortality in Advanced Ovarian Cancer. JAMA Network Open. 8(7). e2523434–e2523434.
2.
Sweeney, Christine T., John L. Dalrymple, Joseph Dottino, et al.. (2024). Implementation of a financial navigation program in gynecologic oncology. Gynecologic Oncology. 189. 119–124.
4.
Naci, Huseyin, et al.. (2024). Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway. Journal of Pharmaceutical Policy and Practice. 17(1). 2351003–2351003. 2 indexed citations
5.
Hacker, Michele R., et al.. (2023). Association of body mass index with early age at diagnosis of endometrial intraepithelial neoplasia. Gynecologic Oncology. 175. 15–19. 1 indexed citations
6.
Siamakpour‐Reihani, Sharareh, Joseph Dottino, Rex C. Bentley, et al.. (2023). High-fat diet and obesity are associated with differential angiogenic gene expression in epithelial ovarian cancer. Gynecologic Oncology. 179. 97–105. 7 indexed citations
7.
Melamed, Alexander, et al.. (2022). Black and Hispanic patient representation in NCCN-recommended systemic therapy regimens for endometrial cancer (015). Gynecologic Oncology. 166. S12–S12. 1 indexed citations
8.
Melendez, Brenda, Sarita R. Shah, Yunyun Jiang, et al.. (2021). Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. Journal of Controlled Release. 339. 521–530. 5 indexed citations
9.
Dottino, Joseph, Emily Hinchcliff, & Haley Moss. (2021). Participation of Black and Hispanic women in clinical trial evidence for NCCN preferred systemic therapies in advanced ovarian cancer. Gynecologic Oncology. 162. S227–S227. 1 indexed citations
10.
González, Rafael I., Laura J. Havrilesky, Evan R. Myers, et al.. (2020). Cost-effectiveness analysis comparing “PARP inhibitors-for-all” to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancer. Gynecologic Oncology. 159(2). 483–490. 24 indexed citations
11.
Dottino, Joseph, Qian Zhang, David S. Loose, et al.. (2020). Endometrial biomarkers in premenopausal women with obesity: an at-risk cohort. American Journal of Obstetrics and Gynecology. 224(3). 278.e1–278.e14. 7 indexed citations
12.
Dottino, Joseph, Weiguo He, Charlotte C. Sun, et al.. (2020). National trends in bowel and upper abdominal procedures in ovarian cancer surgery. International Journal of Gynecological Cancer. 30(8). 1195–1202. 9 indexed citations
13.
Dottino, Joseph, Weiguo He, Charlotte C. Sun, et al.. (2019). Centers for Medicare and Medicaid Services' Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) scores and gynecologic oncology surgical outcomes. Gynecologic Oncology. 154(2). 405–410. 26 indexed citations
14.
Dottino, Joseph, Haley Moss, Karen H. Lu, Angeles Alvarez Secord, & Laura J. Havrilesky. (2019). U.S. Food and Drug Administration–Approved Poly (ADP-Ribose) Polymerase Inhibitor Maintenance Therapy for Recurrent Ovarian Cancer. Obstetrics and Gynecology. 133(4). 795–802. 28 indexed citations
15.
Meyer, Larissa A., Weiguo He, Charlotte C. Sun, et al.. (2018). Neoadjuvant chemotherapy in elderly women with ovarian cancer: Rates of use and effectiveness. Gynecologic Oncology. 150(3). 451–459. 33 indexed citations
16.
Dottino, Joseph, David R. Lairson, Scott B. Cantor, R.S. Suidan, & Karen H. Lu. (2017). A cost-effectiveness analysis of universal testing for Lynch syndrome in endometrial carcinoma. Gynecologic Oncology. 147(1). 203–203. 1 indexed citations
17.
Dottino, Joseph, Vic Hasselblad, Angeles Alvarez Secord, et al.. (2016). Levonorgestrel Intrauterine Device as an Endometrial Cancer Prevention Strategy in Obese Women. Obstetrics and Gynecology. 128(4). 747–753. 10 indexed citations
18.
Dickson, Elizabeth L., Rachel I. Vogel, Paola A. Gehrig, et al.. (2015). A multi-institutional study of outcomes in stage I–III uterine carcinosarcoma. Gynecologic Oncology. 139(2). 275–282. 23 indexed citations
19.
Dottino, Joseph, William A. Cliby, Evan R. Myers, Robert E. Bristow, & Laura J. Havrilesky. (2015). Improving NCCN guideline-adherent care for ovarian cancer: Value of an intervention. Gynecologic Oncology. 138(3). 694–699. 10 indexed citations
20.
Dennis, S., Oliver Zivanovic, Kimberly Levinson, et al.. (2010). The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas. Gynecologic Oncology. 119(1). 38–42. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026